DeepCeutix - AI Co-Scientist for Pharmaceutical Formulation

From early research through regulatory filing, faster with AI.

Meet DEEPC, your AI Co-Scientist. Agentic AI that pulls from FDA, clinical, and safety databases to ground every formulation decision in real evidence.

Your question triggers a search across regulatory databases, clinical trial registries, and peer-reviewed literature. You get formulation candidates back with every source cited.

I'm developing a novel tyrosine kinase inhibitor for EGFR-mutant non-small cell lung cancer. The API is classified as BCS Class II with very poor aqueous solubility (8.5 µg/mL) but high permeability. Our current capsule formulation shows highly variable bioavailability and significant food effects in Phase I trials. I need to explore advanced formulation strategies that can improve dissolution rate, reduce fed/fasted variability, and enable consistent systemic exposure at the 150 mg daily dose.

I'll help you develop an optimized formulation for your BCS Class II tyrosine kinase inhibitor. Let me gather comprehensive data on solubility enhancement technologies and absorption enhancers.

DeepC inverts the R&D ratio: simulate 1,000 candidates, synthesize the winner. Grounded in FDA data, clinical literature, and stability science.